HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A case of bilobar multiple hepatocellular carcinoma in which complete remission was achieved by preoperative percutaneous isolated hepatic perfusion and subsequent hepatectomy].

Abstract
We report a case of bilobar multiple hepatocellular carcinoma (HCC) successfully treated by preoperative percutaneous isolated hepatic perfusion(PIHP) and subsequent hepatectomy. A 77-year-old man with elevated serum PIVKA-II level and hepatomas was referred to our hospital. Abdominal dynamic computed tomography and gadoxetate disodium-enhanced magnetic resonance imaging demonstrated advanced HCCs: 11 tumors with a maximum tumor size of 4.8 cm diameter in the right lobe, and 1 tumor of 3.6 cm diameter in the left lobe. Curative resection was impossible due to insufficient liver function and due to the locations of the tumors. Therefore, we performed preoperative PIHP in order to control the multiple HCCs in the right lobe. This resulted in normalization of serum PIVKA-II level and complete necrosis of all tumors in the right lobe, as observed on dynamic computed tomography after 4 weeks of PIHP. Then, at 7 weeks after PIHP, we performed extended left lobectomy for residual tumor in the left lobe. Finally, complete remission was thought to have been achieved. The patient is alive 6 months after PIHP, without recurrence.
AuthorsTakeshi Urade, Motofumi Tanaka, Takumi Fukumoto, Masahiro Kido, Shinobu Tsuchida, Masanori Takahashi, Atsushi Takebe, Kaori Kuramitsu, Masahide Awazu, Masashi Chuma, Kenji Fukushima, Shinichi So, Kentaro Tai, Masato Fujimoto, Hirochika Toyama, Makoto Shinzeki, Ippei Matsumoto, Tetsuo Ajiki, Yonson Ku
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 39 Issue 12 Pg. 1825-7 (Nov 2012) ISSN: 0385-0684 [Print] Japan
PMID23267899 (Publication Type: Case Reports, English Abstract, Journal Article)
Topics
  • Aged
  • Carcinoma, Hepatocellular (therapy)
  • Hepatectomy
  • Humans
  • Liver Neoplasms (therapy)
  • Male
  • Neoplasms, Multiple Primary (therapy)
  • Remission Induction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: